MedImmune
AstraZeneca/ News/ News/ R&D
AstraZeneca to present the latest cardiovascular research
Piotr Wnuk
AstraZeneca, cardiovascular, hyperkalaemia, MedImmune
0 Comment
AstraZeneca/ News/ News/ R&D/ Top pharmaceutical companies
AZ forges surprise R&D deal with virus gene therapy biotech
Piotr Wnuk
AstraZeneca, gene therapy, genetics, MedImmune
0 Comment
Partner content/ Press releases
MedImmune Expert Speaker Interview released in run up to Immuno-Oncology Conference
Lyudmyla Durneva
cancer, immunooncology, MedImmune
0 Comment
News/ News/ R&D/ Top stories
AstraZeneca’s respiratory biologic fails again in COPD
Linda Banks
AZ, COPD, Fasenra, MedImmune, respiratory biologic, respiratory disease
0 Comment
AstraZeneca (AZ) and MedImmune, have announced that the latest trial of Fasenra (benralizumab) in patients with moderate-to-very-severe chronic obstructive pulmonary disease (COPD) did not provide a statistically-significant reduction in exacerbations.
Oncology/ Views & Analysis/ Views and analysis
Bahija Jallal: pharma’s Woman of the Year in a landmark 12 months
Andrew McConaghie
AstraZeneca, Bahija Jallal, HBA, MedImmune
0 Comment
AstraZeneca’s Bahija Jallal was named the Healthcare Businesswomen’s Association (HBA) Women of the Year for 2017 – in what turned out to a watershed year for women’s rights.
Digital and Social Media/ News/ UK & Europe
MedImmune launches Digital Health Challenge in the UK
Andrew McConaghie
digital health, MedImmune, start ups
0 Comment
Start ups and entrepreneurs in the UK who have developed or are looking to create a digital healthcare solution are being invited to submit entries to a new prize fund organised by Medimmune.
Partner content/ Press releases/ R&D
Hear from MedImmune and Ipsen at SMi’s Injectable Drug Delivery 2018
Pavan Solanki
drug delivery, injectable, Ipsen, MedImmune, syringe
0 Comment
Launch of Injectable Drug Delivery
US authorities refuse to use AZ’s nasal flu vaccine
Richard Staines
AstraZeneca, flu, MedImmune, vaccine
0 Comment
Company takes $80m hit.